0001209191-16-132613.txt : 20160713 0001209191-16-132613.hdr.sgml : 20160713 20160713170813 ACCESSION NUMBER: 0001209191-16-132613 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160713 DATE AS OF CHANGE: 20160713 EFFECTIVENESS DATE: 20160713 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0000707511 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521253406 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-266919 FILM NUMBER: 161766101 BUSINESS ADDRESS: STREET 1: 15245 SHADY GROVE ROAD STREET 2: SUITE 470 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-208-9191 MAIL ADDRESS: STREET 1: 15245 SHADY GROVE ROAD STREET 2: SUITE 470 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA 1 BIOMEDICALS INC DATE OF NAME CHANGE: 19950719 D 1 primary_doc.xml X0707 D LIVE 0000707511 REGENERX BIOPHARMACEUTICALS INC 15245 Shady Grove Road Suite 470 Rockville MD MARYLAND 20850 301-208-9191 DELAWARE Alpha 1 Biomedicals Inc. ALPHA 1 BIOMEDICALS INC Corporation true J.J. Finkelstein 15245 Shady Grove Road Suite 470 Rockville MD MARYLAND 20850 Executive Officer Allan L Goldstein 15245 Shady Grove Road Suite 470 Rockville MD MARYLAND 20850 Director Mauro Bove 15245 Shady Grove Road Suite 470 Rockville MD MARYLAND 20850 Director R Don Elsey 15245 Shady Grove Road Suite 470 Rockville MD MARYLAND 20850 Director Joseph C McNay 15245 Shady Grove Road Suite 470 Rockville MD MARYLAND 20850 Director Pharmaceuticals Decline to Disclose 06b false 2016-06-29 true true true true false 0 Maxim Group LLC 120708 Maxim Group LLC 120708 405 Lexington Avenue New York NY NEW YORK 10174 All States 4375000 4375000 0 The total offering amount and total amount sold include both common stock and warrants to purchase $2,625,000 of common stock. false 2 140000 0 In addition, the selling agent received warrants to purchase 257,353 shares of common stock. 0 false REGENERX BIOPHARMACEUTICALS INC /s/ J.J. Finkelstein J.J. Finkelstein Chief Executive Officer 2016-07-13